THE REPORT of the Study Commission on Pharmacy, made in 1975 and entitled "Pharmacists for the Future," recognized the need to develop "clinical scientists" within the profession of pharmacy.' It was felt that a major function of this clinician/scientist would be to bridge the gap between medicine and the pharmaceutical sciences. Since the report, progress has been made in this area. Clinical pharmacists in academic and government institutions and in the pharmaceutical industry are conducting clinically relevant research in the areas of pharmacokinetics, comparative efficacy, adverse drug reactions, and medication compliance. Significant research contributions have been made by clinical pharmacists in such diverse areas as oncology, hypertension, cardiology, infectious disease, asthma, renal failure, and epilepsy.v'" Despite progress, many academic clinical pharmacists find themselves in a research dilemma. They are expected to perform research if they are to be promoted, but they lack the training and support (i.e., money, space, equipment, and time) to be productive researchers. Deans and department heads make it clear that successful clinical faculty must perform research, but the clinical faculty member is often puzzled by what qualifies as original research and how much must be performed. Usually the only advice is that researchers make sure that manuscripts are accepted in refereed journals. This pressure results in the proliferation of what might be termed soft research (e.g., case reports with a review of the world's literature, surveys of physicians' attitudes toward some aspects of pharmacy practice, or articles starting with the title "The Role of the Pharmacist in . . ."). After reading some of this literature, one wonders if the principal beneficiary was intended to be the reading audience or the author. Alternatively, some schools have attempted to remove research pressure from clinical faculty members by placing them in a nontenure track. This separate classification may produce a J. ROBERT POWELL, Pharm.D., is Associate Professor of Clinical Pharmacy, School of Pharmacy, The University of North Carolina, Chapel Hill, NC 27514. 154 second type of faculty member that may be regarded as second class. This administrative decision also may tend to stifle those who otherwise might become excellent researchers. Although a nontenure-track position may be appropriate for some clinical faculty (and some basic science faculty), it seems wrong to force it on all. Clinical faculty should have a choice.
Recently some schools have implied that the successful faculty member must not only publish, but must also attract large sums of research support. If a farmer wants a cow to produce quality milk, he must first prepare the cow for milk production by introducing her to an amorous bull. To keep the cow producing milk, the farmer feeds her well and keeps her content; then he can milk her regularly. It seems to me that many colleges of pharmacy have not successfully fertilized or prepared the clinical faculty, have not provided the nutrients to sustain quality research, and have not produced the peace of mind required for optimal productivity. Because of this, some clinical faculty personally reject research. Even worse, they may feel threatened by their peers who enjoy research. This can erode the necessary unity of a clinical faculty.
A clinical pharmacist who participates in well-conceived, meaningful research may improve his or her service and teaching functions. After providing service and teaching in the same area for several years, there is an understandable tendency to stagnate. An ongoing research program might be the only dimension that can prevent stagnation and, therefore, provide the fuel for long-term growth. Particularly in an academic medical center, the clinical pharmacist's ability to plan and conduct clinical research in collaboration with medical school faculty may be the ingredient that allows the clinical pharmacist to provide a meaningful service and to be an effective role model for pharmacy students. Equally important is the "halo effect" of collaborative clinical research. Medical residents, interns, and medical students who have read the pharmacist's articles in the Annals of Internal Medicine or the Journal of the American Medical Association are often inclined to listen more carefully to the pharmacist's opinion on treatment. Because of trans-ferred credibility, this occurs even when the clinical problem is unrelated to the pharmacist's research. In this environment pharmacy students benefit by receiving more attention from the attending physician and house staff. Perhaps more importantly, pharmacy students see the preceptor as a respected peer of the medical establishment.
If clinical pharmacists in colleges of pharmacy are expected to be successful researchers, training programs must be established to make them competent researchers. The most effective way to accomplish this task is to establish research fellowships. Although many Pharm.D. programs have students perform a "research" project, there is too much to learn about drugs and diseases to be concerned about developing research skills. Fellowships have been conducted at Buffalo, Minneapolis, New Haven, and San Francisco, but there are too few positions and the duration of the fellowship is frequently only one year. Some fellowships are more like traditional hospital pharmacy residencies, placing emphasis on service and teaching activities. Clinical research fellowships should be for a minimum of two years and should be designed to produce effective, independent clinical researchers. Although fellowships should be devoted principally to the development of research skills, time must be provided for a minimal amount of clinical activity to maintain the participant's clinical competence. The first six months of the fellowship could be used to take background courses (e.g., biostatistics, epidemiology, drug analysis and instrumentation, cardiovascular pharmacology, and pharmacokinetics), to interview and select a research advisor and project, to submit research protocols to the required human or animal experimentation committees, and to start learning the required analytical techniques. Ideally, the fellow would choose a research advisor who would incorporate the fellow into an ongoing research program. If a fellowship is for only one year, the fellow may find that his or her research experience must be prematurely concluded. During a second year, course work may continue, research can be concluded, and manuscripts can be prepared for publication. Since fellowships are generally of a rather short and fixed duration, compared with graduate programs, time must be spent efficiently and the chance of success must be optimized. Funding for these fellowships should be sought from government, industry, and private foundations.
A more immediate problem is how to train current clinical faculty in research techniques. First, time must be allocated to pursue research interests and to take courses. Given the time, some clinical pharmacists successfully gain research experience from established researchers who enjoy helping others. There are many scientists in colleges of pharmacy who have gone out of their way to pique the research interests of clinical pharmacists and to help develop research skills. Colleges should provide the clinical pharmacist with the option of sabbatical leaves for the express purpose of developing research skills.
Colleges must provide clinical faculty with resources for conducting research. Many clinical pharmacists are currently forced to engage in "guerrilla research." They beg, borrow, or steal equipment and other resources to complete projects successfully. They perform drug analyses in the evenings or on weekends when an instrument is not being used, or they may convince people in different labs to perform portions of the research for them. Although this teaches one to be resourceful, this type of research is inefficient and tends to be short-sighted. It is hard to develop a longrange research plan in such a situation.
For those who successfully run this gauntlet, care must be taken to avoid research elitism. It is easy to neglect service and teaching responsibilities in favor of expanding research interests. In addition, some of the best research ideas stem from clinical problems that are encountered only by seeing patients and interacting with physicians who treat patients. 'The successful clinical pharmacy researcher may spend a small percentage of time in teaching or service activity. This usually means that other faculty members take up the slack -willingly or not. Administrators may promote the successful researcher more rapidly than a faculty member who excels at teaching and service; publications and grants are more easily documented than teaching and service. For clinical pharmacy faculty, it seems that teaching, service, and research should be given equal weight by administrators. To deviate radically from this balance can produce a distorted program and a discontented clinical faculty. If a program attaches equal weight to these three functions, it does not mean that each faculty member must necessarily achieve the same balance.
These problems are solved by administrative decisions. Unfortunately, most pharmacy deans have no direct experience in clinical pharmacy and most clinical pharmacy administrators have no research experience. Hence, the problems of the clinical pharmacist researcher may not be appreciated by administrators.
The goals of every clinical pharmacy program should be clear to both clinical faculty and administrators. The expectations of each clinical faculty member should be evident to the faculty member and to the faculty as a whole so that future rewards or penalties for job performance are neither arbitrary nor unfair.
Some clinical pharmacists have demonstrated success in research. However, this success is the product of luck, tenacity, hard work, and the unselfish leadership of several established scientists in pharmacy schools rather than of a carefully planned training and development program. In the future, colleges of pharmacy must establish research fellowships for clinical pharmacists and must provide the opportunity for present clinical faculty to improve research productivity. Colleges should recognize the additional burden of clinical service and should treat clinical faculty at least equitably with basic science faculty in regard to time and resources forresearch, Support from the federal government and the pharmaceutical industry for research training programs would accelerate the process. The Study Commission on Pharmacy correctly foresaw the role of the clinical pharmacist in research, but the full impact of the clinical scientist on the pharmacy profession and society must await the establishment of research training programs and support for clinical pharmacists. 
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